adenoassoci
viru
aav
promis
genedeliveri
vector
test
novel
duchenn
muscular
dystrophi
gene
therapi
canin
model
humor
immun
greatli
influenc
vivo
aav
transduct
howev
neutral
antibodi
system
examin
normal
dystroph
dog
gain
inform
seropreval
antibodi
measur
neutral
antibodi
titer
use
vitro
transduct
inhibit
assay
examin
naiv
serum
sampl
serum
sampl
obtain
dog
receiv
aav
gene
transfer
data
demonstr
neutral
antibodi
preval
antibodi
dog
irrespect
age
gender
diseas
statu
dystroph
prior
parvoviru
vaccin
histori
surprisingli
highlevel
antibodi
detect
birth
newborn
puppi
robust
antibodi
respons
induc
affect
normal
newborn
dog
follow
system
aav
gene
transfer
taken
togeth
data
provid
import
baselin
seropreval
neutral
antibodi
normal
duchenn
muscular
dystrophi
dog
result
help
guid
translat
aav
genetherapi
studi
dog
model
muscular
dystrophi
uchenn
muscular
dystrophi
dmd
xlink
lethal
muscl
diseas
caus
dystrophin
defici
dystrophin
gene
one
largest
gene
genom
code
sequenc
yield
subsarcolemm
cytoskelet
protein
call
dystrophin
dystrophin
essenti
surviv
striat
muscl
cell
absenc
dystrophin
myocyt
undergo
necrosi
eventu
replac
noncontractil
fibrot
andor
fatti
tissu
highli
truncat
microdystrophin
gene
artifici
engin
dystrophin
gene
fit
capsid
adenoassoci
viru
aav
parvovirusderiv
genedeliveri
vector
despit
signific
abbrevi
code
sequenc
microdystrophin
gene
shown
protect
skelet
muscl
heart
mous
dmd
model
aav
gene
transfer
wang
et
al
harper
et
al
yue
et
al
yue
et
al
gregorev
et
al
bostick
et
al
critic
next
step
determin
whether
microgen
effect
amelior
muscl
diseas
canin
dmd
model
duan
spontan
dystrophin
mutat
report
dozen
dog
breed
duan
sever
case
coloni
establish
cooper
et
al
kornegay
et
al
fine
et
al
smith
et
al
clinic
histolog
immunolog
physiolog
studi
suggest
dystrophinnul
dog
excel
dmd
model
addit
larg
bodi
size
dystroph
dog
manifest
progress
muscl
wast
diseas
seen
human
patient
shelton
engval
duan
recent
studi
suggest
dmd
dog
may
repres
better
model
studi
aav
immun
respons
context
muscular
dystrophi
wang
et
al
yue
et
al
shin
et
al
outcom
aav
gene
therapi
determin
mani
factor
among
viral
serotyp
preexist
immun
gao
et
al
vandenbergh
wilson
zaiss
muruv
mingozzi
high
current
promis
aav
serotyp
canin
dmd
genetherapi
studi
wang
et
al
yue
et
al
gregorev
et
al
ohshima
et
al
unfortun
humor
respons
aav
serotyp
fulli
appreci
dog
either
normal
dystroph
rapti
et
al
studi
preval
neutral
antibodi
nab
sampl
normal
carrier
affect
dog
locat
two
geograph
distant
institut
auburn
univers
auburn
al
univers
missouri
columbia
mo
age
serum
collect
rang
within
hr
birth
approxim
year
baselin
nab
titer
determin
dog
expos
aav
vector
influenc
dystrophin
gene
mutat
wild
type
carrier
affect
gender
prior
exposur
parvoviru
vaccin
evalu
case
newborn
dog
also
correl
nab
titer
dam
studi
nab
chang
neonat
puppi
receiv
system
aav
infect
adult
dog
challeng
intramuscular
aav
inject
anim
experi
approv
anim
care
use
committe
auburn
univers
univers
missouri
accord
nation
institut
health
guidelin
experiment
dog
normal
carrier
affect
gener
hous
either
auburn
univers
univers
missouri
dog
either
pure
breed
beagl
golden
retriev
labrador
retriev
welsh
corgi
mix
background
due
intercross
among
four
pure
breed
dog
produc
use
artifici
insemin
affect
dog
carri
one
two
three
differ
mutat
dystrophin
gene
mutat
includ
follow
point
mutat
g
transit
near
end
intron
mutat
disrupt
normal
splice
result
outoffram
transcript
miss
exon
sharp
et
al
origin
report
golden
retriev
muscular
dystrophi
dog
insert
repetit
element
intron
smith
et
al
mutat
origin
found
welsh
corgi
muscular
dystrophi
dog
insert
repetit
element
intron
smith
et
al
fine
et
al
mutat
origin
found
labrador
retriev
muscular
dystrophi
dog
genotyp
experiment
subject
determin
pcr
accord
publish
protocol
fine
et
al
smith
et
al
yue
et
al
case
diagnosi
confirm
serum
creatin
kinas
level
muscl
immunostain
use
dystrophinspecif
antibodi
dog
immun
vaccin
month
old
multival
vaccin
protect
dog
sever
canin
virus
includ
canin
distemp
viru
adenoviru
parainfluenza
viru
canin
coronaviru
canin
parvoviru
three
differ
aav
serotyp
use
studi
tyrosin
mutant
tyrosin
mutant
zhong
et
al
qiao
et
al
tyrosin
mutant
aav
ident
origin
serotyp
except
replac
singl
tyrosin
residu
phenylalanin
indic
posit
vector
express
either
heatresist
human
placent
alkalin
phosphatas
gene
driven
rou
sarcoma
viru
promot
cytomegaloviru
promoterdriven
canin
microdystrophin
gene
lai
et
al
shin
et
al
recombin
aav
stock
gener
accord
publish
protocol
bostick
et
al
ghosh
et
al
yue
et
al
yue
et
al
qiao
et
al
neonat
system
gene
deliveri
recombin
aav
inject
puppi
via
jugular
vein
local
muscl
gene
transfer
perform
adult
dystroph
dog
either
without
immun
suppress
transient
immun
suppress
use
cyclosporin
mycophenol
mofetil
newborn
puppi
aav
inject
conduct
auburn
univers
univers
missouri
adult
dog
inject
conduct
univers
missouri
age
dog
serum
collect
rang
day
day
birth
day
nab
assay
conduct
sampl
detail
blind
assay
perform
prior
measur
nab
serum
heatinactiv
min
nab
assay
perform
cell
previous
describ
use
multipl
infect
moi
serotyp
calcedo
et
al
brief
genom
copi
recombin
aavcmvlacz
per
well
dilut
serumfre
dulbecco
modifi
eagl
medium
dmem
incub
twofold
serial
dilut
initi
dilut
heatinactiv
serum
sampl
dmem
hr
subsequ
serumvector
mixtur
ad
plate
cellswel
infect
hr
earlier
wildtyp
human
adenoviru
moi
viral
particlescel
one
hour
later
well
supplement
equal
volum
fetal
bovin
serum
dmem
incub
hr
co
cell
wash
twice
phosphatebuff
salin
final
cell
lyse
lysat
develop
mammalian
bgalactosidas
assay
kit
accord
manufactur
instruct
appli
biosystem
carlsbad
ca
bioluminesc
quantifi
use
clariti
softwaredriven
micropl
luminomet
biotek
winooski
vt
nab
titer
report
highest
serum
dilut
inhibit
aavcmvlacz
transduct
bgalactosidas
express
cell
compar
naiv
mous
serum
control
sigma
st
loui
mo
limit
detect
data
present
mean
sem
statist
signific
two
group
analyz
student
test
comparison
multipl
group
analyz
oneway
analysi
varianc
anova
follow
bonferroni
post
hoc
analysi
spss
chicago
il
p
valu
consid
statist
signific
dog
sera
collect
coloni
locat
either
auburn
univers
univers
missouri
similar
result
obtain
coloni
present
purpos
data
combin
total
serum
sampl
naiv
dog
serum
sampl
aavinfect
dog
examin
nab
detect
limit
shin
et
al
normal
dystroph
dog
show
high
preval
nab
determin
preexist
immun
dog
measur
nab
serotyp
sera
collect
dog
span
wide
age
rang
adult
fig
tabl
normal
dog
high
level
nab
detect
right
birth
high
nab
persist
dog
month
old
adult
normal
dog
still
carri
nab
titer
lower
fig
nab
rare
detect
fig
tabl
except
young
dog
less
month
show
margin
level
nab
titer
assay
limit
major
dog
similar
profil
found
carrier
dog
affect
dog
fig
c
tabl
dog
nab
remain
preval
detect
everi
serum
sampl
normal
affect
dog
nab
found
serum
sampl
titer
interestingli
frequenc
detect
nab
seem
slightli
increas
carrier
dog
approxim
carrier
posit
nab
posit
nab
confirm
observ
perform
western
blot
use
sera
naiv
adult
dog
immunoblot
studi
also
show
high
level
nab
supplementari
fig
supplementari
data
avail
onlin
wwwliebertonlinecomhum
minim
reactiv
supplementari
fig
determin
whether
dystrophin
gene
mutat
influenc
nab
titer
group
result
accord
genotyp
fig
similar
trend
found
normal
carrier
affect
dog
show
high
level
nab
fig
impact
parvoviru
immun
gender
humor
immun
dog
immun
vaccin
week
age
multival
vaccin
contain
compon
canin
parvoviru
test
whether
vaccin
influenc
develop
aav
nab
compar
result
dog
vaccin
fig
surprisingli
vaccin
rais
titer
aav
nab
fig
interestingli
titer
vaccin
dog
older
month
significantli
lower
prevaccin
dog
newborn
month
old
test
also
compar
gender
differ
expect
differ
notic
male
femal
dog
fig
character
preexist
nab
dog
profil
kinet
nab
differ
age
fig
b
shown
fig
nab
becam
detect
day
birth
intriguingli
puppi
show
nab
titer
significantli
higher
dam
oneway
anova
puppi
also
significantli
higher
nab
titer
test
fig
dog
age
nab
titer
diminish
fig
adult
dog
nab
titer
stay
despit
coincid
serum
sampl
collect
januari
septemb
nab
appear
consist
high
irrespect
month
serum
collect
fig
ac
nab
titer
differ
age
normal
affect
carrier
dog
pleas
note
sampl
size
reflect
graph
mani
case
result
sever
dog
age
ident
correl
diseas
statu
seropreval
affect
normal
group
data
male
femal
dog
pool
affect
male
carri
dystrophin
gene
mutat
x
chromosom
affect
femal
carri
dystrophin
gene
mutat
x
chromosom
normal
dog
carri
dystrophin
gene
mutat
carrier
group
consist
femal
dog
one
normal
x
chromosom
one
dystrophin
genemut
x
chromosom
n
normal
dog
n
affect
dog
n
carrier
dog
antibodi
titer
significantli
differ
antibodi
titer
categori
normal
carrier
affect
assess
impact
aav
gene
transfer
nab
develop
perform
system
aav
deliveri
newborn
puppi
direct
muscl
inject
adult
dog
fig
four
normal
newborn
puppi
inject
aav
via
jugular
vein
among
two
receiv
intraven
tyrosin
mutant
inject
birth
month
age
yield
nab
differ
uninfect
dog
fig
interestingli
dog
also
develop
mild
moder
nab
two
dog
administ
tyrosin
mutant
born
fig
month
inject
neither
posit
nab
none
inject
normal
newborn
develop
nab
fig
three
newborn
dystroph
dog
receiv
system
gene
transfer
two
develop
high
nab
titer
third
borderlin
nab
one
dog
also
show
respons
five
affect
dog
inject
tyrosin
mutant
via
jugular
vein
birth
fig
develop
robust
persist
nab
last
least
month
year
last
measur
fig
four
also
develop
nab
nab
differ
uninfect
dystroph
dog
transient
immun
suppress
reduc
humor
respons
adult
dog
receiv
local
muscl
aav
inject
tyrosin
mutant
inject
directli
limb
muscl
one
normal
dog
dog
develop
extrem
high
nab
titer
fig
nab
also
slightli
increas
dog
anoth
normal
dog
tyrosin
mutant
deliv
limb
muscl
dog
transient
immunesuppress
cyclosporin
mycophenol
mofetil
humor
respons
substanti
reduc
nab
detect
nab
fig
two
affect
dog
receiv
muscl
inject
tyrosin
mutant
aav
deliveri
perform
dog
transient
immun
suppress
aav
inject
moder
level
nab
gene
transfer
titer
increas
substanti
fig
howev
never
reach
level
seen
normal
dog
receiv
direct
muscl
inject
tyrosin
mutant
absenc
immun
suppress
fig
studi
character
sever
featur
humor
immun
normal
carrier
dmd
dog
strike
find
high
preval
nab
naiv
dog
fig
tabl
high
nab
titer
found
everi
dog
irrespect
dystrophin
genotyp
wildtyp
mutat
fig
also
influenc
locat
coloni
auburn
univers
auburn
al
univers
missouri
columbia
mo
dog
gender
time
year
serum
collect
canin
parvoviru
vaccin
alter
preexist
nab
titer
either
fig
sharp
contrast
nab
rare
detect
fig
tabl
correl
parvoviru
vaccin
nab
n
unvaccin
dog
n
vaccin
dog
antibodi
titer
unvaccin
normal
dog
significantli
higher
vaccin
normal
dog
oneway
anova
b
comparison
seropreval
male
femal
dog
n
male
n
femal
origin
isol
adenoviru
stock
rutledg
et
al
howev
may
actual
repres
natur
recombin
first
nucleotid
ident
remain
nucleotid
ident
xiao
et
al
also
isol
adenoviru
stock
atchison
et
al
xiao
et
al
isol
pcr
rhesu
monkey
human
tissu
respect
gao
et
al
gao
et
al
gener
accept
preexist
immun
specif
aav
serotyp
due
previou
exposur
serotyp
natur
infect
low
incid
nab
consist
model
high
level
seroposit
howev
unexpect
although
complet
exclud
nonimmunoglobulin
inhibitori
factor
recent
studi
rapti
cowork
reveal
trend
similar
observ
rapti
et
al
exact
reason
known
intriguingli
high
preval
nab
naiv
dog
sever
hypothes
may
worth
pursu
first
dog
companion
anim
human
previou
studi
suggest
human
popul
seroposit
halbert
et
al
calcedo
et
al
possibl
dog
infect
owner
infect
second
possibl
crossreact
antibodi
canin
parvoviru
thirdli
may
exist
yet
undefin
protein
dog
sera
specif
interact
capsid
addit
studi
need
fulli
understand
seroposit
dog
high
frequenc
nab
dog
may
import
implic
preclin
studi
canin
model
one
hand
anteced
nab
may
block
aav
transduct
pollock
carmichael
hurlbut
et
al
wang
et
al
hand
may
repres
golden
opportun
develop
genetherapi
strategi
treatment
seroposit
patient
exampl
explor
differ
immunesuppress
scheme
fig
wang
et
al
gregorev
et
al
shin
et
al
surpris
find
high
nab
titer
newborn
puppi
fig
dog
multipar
anim
structur
placenta
differ
human
essenc
matern
fetal
blood
separ
dog
minim
transfer
matern
antibodi
fetu
placenta
felsburg
day
newborn
dog
obtain
passiv
immun
primarili
colostrum
highli
enrich
immunoglobulin
reynold
johnson
heddl
rowley
korhonen
et
al
schafersomi
et
al
importantli
newborn
puppi
digest
tract
special
adapt
immunoglobulin
absorpt
via
fcrn
receptor
felsburg
day
suggest
level
puppi
serum
igg
may
reach
dam
via
suckl
colostrum
felsburg
univers
presenc
nab
dog
fig
supp
fig
reason
assum
nab
puppi
transfer
dam
colostrum
howev
complet
explain
observ
found
neonat
show
significantli
higher
nab
titer
dam
anoth
peculiar
find
studi
reduct
nab
parvoviru
vaccin
immun
fig
worth
point
vaccin
dog
significantli
older
prevaccin
dog
month
versu
month
regard
exclud
age
effect
indepth
investig
need
clarifi
provok
observ
perhap
strike
find
distinct
humor
respons
normal
affect
puppi
neonat
system
aav
inject
fig
well
document
puppi
born
function
b
cell
cell
review
see
felsburg
felsburg
day
despit
immun
matur
interestingli
intraven
aav
administr
induc
notic
bcell
respons
normal
puppi
composit
peripher
lymphocyt
differ
neonat
adult
newborn
puppi
thymu
contain
much
fewer
cell
absolut
number
review
see
felsburg
felsburg
day
yet
demonstr
whether
differ
contribut
lack
humor
respons
normal
puppi
robust
nab
detect
affect
neonat
puppi
subsequ
system
aav
deliveri
fig
one
factor
worth
consid
passiv
immun
obtain
colostrum
felsburg
signific
differ
newborn
normal
affect
puppi
suckl
abil
dystrophinnul
dog
usual
much
weaker
duan
shin
yue
unpublish
observ
suspect
affect
puppi
may
fail
compet
colostrum
normalcarri
sibl
may
result
hypogammaglobulinemia
reduc
matern
protect
may
thu
contribut
high
humor
respons
dystrophindefici
puppi
support
notion
shown
phage
antigen
induc
antibodi
respons
newborn
puppi
depriv
colostrum
felsburg
felsburg
addit
studi
colostrum
colostrum
substitut
supplement
may
test
hypothesi
poffenbarg
et
al
bouchard
et
al
adult
dog
show
expect
respons
local
aav
inject
fig
nevertheless
appear
transient
immun
suppress
may
greatli
blunt
humor
respons
adult
dog
wang
et
al
shin
et
al
number
factor
contribut
outcom
gene
therapi
studi
conduct
rel
largescal
survey
seropreval
nab
normal
carrier
dystrophindefici
dog
also
examin
antibodi
respons
aav
gene
transfer
neonat
adult
dog
high
preval
nab
especi
newborn
puppi
quit
remark
fig
rapti
et
al
consid
perform
dog
studi
neonat
intraven
aav
deliveri
may
lead
bodywid
muscl
transduct
dog
surprisingli
observ
differ
antibodi
respons
normal
affect
puppi
fig
result
highlight
potenti
challeng
test
wholebodi
gene
therapi
newborn
dystroph
dog
summari
studi
establish
baselin
assess
novel
aav
gene
therapi
dog
model
work
support
grant
nation
institut
health
muscular
dystrophi
associ
parent
project
muscular
dystrophi
jess
journey
foundat
gene
cell
therapi
thank
dr
arun
srivastava
univers
florida
provid
tyrosin
mutant
aav
packag
plasmid
thank
immunolog
core
gene
therapi
program
fig
develop
nab
follow
intravascular
inject
newborn
dog
two
normal
puppi
five
affect
puppi
receiv
system
tyrosin
mutant
within
hr
birth
nab
titer
determin
week
age
asterisk
significantli
differ
normal
dog
test
b
time
cours
nab
develop
five
affect
puppi
receiv
neonat
intraven
tyrosin
mutant
inject
shin
et
al
